{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:58:57Z","timestamp":1782997137309,"version":"3.54.5"},"reference-count":12,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,7,1]]},"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:p>Haemolytic disease of the fetus and newborn (HDFN) is associated with red cell antibodies. Anti-M usually results in a mild haemolysis and is rarely clinically significant. There is no established consensus on management of pregnancies with anti-M. A case of recurrent HDFN with maternal M alloimmunisation was identified at a tertiary hospital in Australia. We collected the patient and neonate\u2019s clinical and pathological data and interpreted the case with available literature. This is the first case in literature of recurrent fetal hydrops in the setting of M alloimmunisation. Neonate was delivered in a poor condition, intubated and admitted to the neonatal intensive care unit for ionotropic support, red cell transfusion and plasma transfusion for coagulopathy. Direct Coombs test was positive, confirming HDFN. Although anti-M rarely causes HDFN, accurate history, fetal surveillance and monitoring is essential for identification of fetal anaemia. Concurrent placental disease may increase fetal risk from anti-M antibodies.<\/jats:p>","DOI":"10.1136\/bcr-2019-230552","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T05:29:02Z","timestamp":1563773342000},"page":"e230552","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Recurrent fetal hydrops with maternal M alloimmunisation: not a benign condition"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6853-4530","authenticated-orcid":false,"given":"Michelle","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Westmead Hospital, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Graham","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology, Westmead Hospital, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Pasalic","sequence":"additional","affiliation":[{"name":"Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thushari Indika","family":"Alahakoon","sequence":"additional","affiliation":[{"name":"Westmead Institute for Maternal and Fetal Medicine, Westmead Hospital, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,7,21]]},"reference":[{"key":"2025082700071885000_12.7.e230552.1","unstructured":"Royal College of Obstetricians and Gynaecologists. The Management of Women with Red Cell Antibodies during Pregnancy. RCOG Green\u2010top Guideline No. 65. London: RCOG, 2014."},{"key":"2025082700071885000_12.7.e230552.2","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1055\/s-0037-1607028","article-title":"Anti-M Alloimmunization: Management and Outcome at a Single Institution","volume":"7","author":"Stetson","year":"2017","journal-title":"AJP Rep"},{"key":"2025082700071885000_12.7.e230552.3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1537-2995.2007.01625.x","article-title":"Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands","volume":"48","author":"Koelewijn","year":"2008","journal-title":"Transfusion"},{"key":"2025082700071885000_12.7.e230552.4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review","volume":"120","author":"Moise","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2025082700071885000_12.7.e230552.5","doi-asserted-by":"publisher","DOI":"10.3109\/00016349609033344"},{"key":"2025082700071885000_12.7.e230552.6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1537-2995.2007.01209.x","article-title":"Fetal hemolytic anemia and intrauterine death caused by anti-M immunization","volume":"47","author":"Wikman","year":"2007","journal-title":"Transfusion"},{"key":"2025082700071885000_12.7.e230552.7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/0973-6247.150968","article-title":"Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins","volume":"9","author":"Arora","year":"2015","journal-title":"Asian J Transfus Sci"},{"key":"2025082700071885000_12.7.e230552.8","first-page":"607","article-title":"Severe hemolytic disease of the newborn caused by anti-m antibodies","volume":"23","author":"Duro","year":"2013","journal-title":"Iran J Pediatr"},{"key":"2025082700071885000_12.7.e230552.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2013.10.002","article-title":"Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature","volume":"28","author":"Yasuda","year":"2014","journal-title":"Transfus Med Rev"},{"key":"2025082700071885000_12.7.e230552.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.06.078"},{"key":"2025082700071885000_12.7.e230552.11","first-page":"8A","article-title":"Neonatal pure red cell aplasia due to maternal anti-M","volume":"96","author":"Nolan","year":"2000","journal-title":"Blood"},{"key":"2025082700071885000_12.7.e230552.12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00006254-198909000-00001","article-title":"Anti-M antibody in pregnancy","volume":"44","author":"Thompson","year":"1989","journal-title":"Obstet Gynecol Surv"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-230552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:07:33Z","timestamp":1756278453000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-230552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":12,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,21]]},"published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1136\/bcr-2019-230552"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-230552","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}